Last edition
News about "US FDA Accelerated Approval"
US FDA Approves First Plasmid DNA-based Immunotherapy
The US FDA has approved the first plasmid DNA-based immunotherapy for adults with recurrent respiratory papillomatosis, targeting the disease at its source.
US FDA Accelerated Approval | 02/11/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members